Dopamine Hydrochloride Injection, Solution
Product Images NDC 51662-1316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride (NDC 51662-1316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (Container Label)

Bag Label (Container Label)
This is a medication called Dopamine HCI with 160 mg of dopamine hydrochloride and 5 g of dextrose, hydrous in each 100 mL. It is used for intravenous injection and contains sodium metabisulfite as an additive. The container is for single use only, and any unused portion should be discarded. The medication should be used promptly after the overwrap is opened, and if there are any defects or darkening, it should also be discarded. It should be stored at controlled room temperature and protected from freezing. The medication is manufactured by Hospira, Inc.*
FDA Label Image

Dosage 1 (Dosage And Administration 1)

FDA Label Image

Dosage 2 (Dosage And Administration 2)

FDA Label Image

Dosage 3 (Dosage And Administration 3)

FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
This is a product description of Total Strength/Total Unit of Sale Volume available in different concentrations and sizes with NDC codes. It is a medication that comes in a carton and is available in different strengths as specified by the concentration in each carton. However, the has made a mistake in interpreting some characters resulting in the appearance of 'mcg/mlL' and 'meg/ml' which may not be accurate.*
FDA Label Image
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
This text provides important information on how to prevent tissue damage in ischemic areas. To do so, it suggests promptly infiltrating the affected area with a solution of 0.9% Sodium Chloride Injection, USP, containing 5 to 10 mg of Regitine (phentolamine), an adrenergic blocking agent. It also notes that the recommended pediatric dosage of Regitine is 0.1-0.2 mg/kg up to a maximum of 10 mg per dose. To administer the solution, a fine hypodermic needle should be used, and it should be widely infiltrated throughout the ischemic area. The text also explains that administering phentolamine in this way causes immediate and noticeable changes in the affected area, so it is important to do so as soon as possible after noticing any symptoms.*
FDA Label Image

Serialized Labeling (Serialized Label Resized)

FDA Label Image

Structure 1 (Structure 1)

FDA Label Image

Structure 2 (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.